Help us improve our website

Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 8 of 8 items.

" " Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels Starting date: December 23, 2020 Posting date: December 23, 2020 Type of communication: Dear…
AlertHealth professional risk communication | 2020-12-23
" " Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: December 18, 2020 Posting date: December 18, 2020 Type of…
AlertHealth professional risk communication | 2020-12-18
" " Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies Starting date: December 12, 2020 Posting date: December 12, 2020 Type of…
AlertPublic advisory | 2020-12-12
" " Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels Starting date: December 12, 2020 Posting date: December 12, 2020 Type of…
AlertHealth professional risk communication | 2020-12-12
" " Hoffman-La Roche Herceptin Product Recall (2020-06-27)
Hoffman-La Roche Herceptin Product Recall (2020-06-27) Starting date: June 27, 2020 Type of communication: Drug Recall Subcategory: Drugs, Biologic/vaccine Hazard…
RecallHealth product recall | 2020-06-27
" " Clinical trial looking at the potential use of convalescent plasma to treat COVID-19
Clinical trial looking at the potential use of convalescent plasma to treat COVID-19 Starting date: May 1, 2020 Type of communication: Advisory Subcategory: Biologic/vaccine…
AlertPublic advisory | 2020-05-01
" " Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection…
AlertHealth professional risk communication | 2020-04-17
" " Hizentra (2020-01-16)
Hizentra (2020-01-16) Starting date: January 16, 2020 Type of communication: Drug Recall Subcategory: Drugs, Biologic/vaccine Hazard classification: Type II Source of recall:…
RecallHealth product recall | 2020-01-16
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.